Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Gastric Cancer: early-phase trial registry
72 of 159 indexed Gastric Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #69 of 28,707 conditions by registered trial count.
159 US clinical trials · 72 currently recruiting · #69 of 28,707 conditions by registered trial count
Gastric Cancer: 159 US clinical trials tracked, 72 recruiting.
Gastric Cancer is the subject of 159 registered US clinical trials on ClinicalTrials.gov, 72 of them currently open to new participants. 17 are in Phase 3-4 (later-stage) and 118 in Phase 1-2 (earlier-stage). The most active sponsor is AstraZeneca, running 11 of these trials.
Enrollment posture brief
Registry condition gastric-cancer
OPEN 72 | RECR 45% | LATE 17 | EARLY 118 | RANK #69 | SPON 11
Volume-matched condition peers
Nearest open-share peer: Non-Small Cell Lung Cancer (45% recruiting · 455 trials)
Gastric Cancer lists 72 open slots (45% of 159 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Gastric Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Gastric Cancer is recruiting above its size-band peers.
72 of 159 indexed trials (45.3%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Gastric Cancer trials is spread across many organizations.
AstraZeneca accounts for 11 of 159 trials (6.9%). 107 distinct sponsors appear on at least one study for this condition label.
-
Typical Gastric Cancer enrolment sits around 117 participants.
Median target enrolment is 117 among the 154 trials that report a genuine target (sentinel values excluded). 65 of those (42.2%) plan for fewer than 100 participants.
-
Gastric Cancer research is mostly interventional.
142 interventional and 17 observational studies make up this index (89.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
159 total, page 4 of 4
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers
University of Southern California
NCT00183846
Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial
National Cancer Institute (NCI)
NCT00941655
Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma
Memorial Sloan Kettering Cancer Center
NCT01491698
Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis
National Cancer Institute (NCI)
NCT04034251
Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
SWOG Cancer Research Network
NCT00032123
BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
Bristol-Myers Squibb
NCT00017043
T900607 in Treating Patients With Gastroesophageal Junction Cancer
University Hospitals Seidman Cancer Center
NCT00054249
DX-8951f in Treating Patients With Metastatic Stomach Cancer
Daiichi Sankyo
NCT00017212
Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
Radiation Therapy Oncology Group
NCT00009880
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 69 |
| Phase 2 | 49 |
| Phase 3 | 13 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Gastric Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Gastric Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Gastric Cancer page
159 registered trials, 72 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 72 Gastric Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AstraZeneca sponsors the most Gastric Cancer trials on record, review their full trial history before evaluating a specific study. See AstraZeneca's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gastric Cancer condition card totals 159 registered trials; most-linked intervention Paclitaxel; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.